Gossamer Bio Inc (GOSS)vsRevolution Medicines Inc (RVMD)
GOSS
Gossamer Bio Inc
$10.73
+7435.11%
HEALTHCARE · Cap: $81.83M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Gossamer Bio Inc generates 7081% more annual revenue ($53.29M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -235.0%. GOSS earns a higher WallStSmart Score of 29/100 (F).
GOSS
Avoid29
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -783.0% — below average capital efficiency
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : GOSS
The strongest argument for GOSS centers on Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : GOSS
The primary concerns for GOSS are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
GOSS profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
GOSS carries more volatility with a beta of 2.01 — expect wider price swings.
GOSS is growing revenue faster at -19.6% — sustainability is the question.
GOSS generates stronger free cash flow (-39M), providing more financial flexibility.
Bottom Line
GOSS scores higher overall (29/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Gossamer Bio Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?